Abstract
AB132. P108. Intraoperative radiotherapy (IORT) followed by concurrent chemotherapy (CCRT) or stereotactic radiotherapy (SBRT) for locally advanced pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB132
(23 April 2018)
Abstract
AB131. P107. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB131
(23 April 2018)
Abstract
AB130. P106. Threedimensional visualization technology used in pancreatic surgery: a valuable tool for surgical trainees
Annals of Pancreatic Cancer
2018;
1:
AB130
(23 April 2018)
Abstract
AB129. P105. A comparative study of the totally onelayer and stratified pancreaticojejunostomy in pancreaticoduodenectomy
Annals of Pancreatic Cancer
2018;
1:
AB129
(23 April 2018)
Abstract
AB128. P104. Gemcitabine/ taxane adjuvant therapy with chemoradiation in resected pancreatic cancer: a novel strategy for improved survival?
Annals of Pancreatic Cancer
2018;
1:
AB128
(23 April 2018)
Abstract
AB127. P103. Evaluation of new stent for EUS-guided pancreatic duct drainage: longterm follow-up outcome
Annals of Pancreatic Cancer
2018;
1:
AB127
(23 April 2018)
Abstract
AB126. P102. Clinicopathological feature of early-stage pancreatic cancer—tumor size was less than 10 mm
Annals of Pancreatic Cancer
2018;
1:
AB126
(23 April 2018)
Abstract
AB125. P101. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis
Annals of Pancreatic Cancer
2018;
1:
AB125
(23 April 2018)
Abstract
AB124. P100. The prevalence and characteristics of pancreatic solid pseudopapillary tumor associate with malignance: a multicenter retrospective study in China
Annals of Pancreatic Cancer
2018;
1:
AB124
(23 April 2018)
Abstract
AB123. P099. Type 2 diabetes mellitus, a vital and independent risk factor for acute pancreatitis in patients with severe hypertriglyceridemia
Annals of Pancreatic Cancer
2018;
1:
AB123
(23 April 2018)
Abstract
AB122. P098. The effect of somatostatin analogues on postoperative outcomes following pancreatic surgery: a meta-analysis
Annals of Pancreatic Cancer
2018;
1:
AB122
(23 April 2018)
Abstract
AB121. P097. Retrospective comparison analysis between pathology and the fukuoka consensus in resected IPMN in a single center
Annals of Pancreatic Cancer
2018;
1:
AB121
(23 April 2018)
Abstract
AB120. P096. A new pancreatojejunostomy of ductto- mucosa combining “backto- back” cross horizontal mattress anastomosis reduce postoperative pancreatic fistula
Annals of Pancreatic Cancer
2018;
1:
AB120
(23 April 2018)
Abstract
AB119. P095. Organ preserving pancreatectomy for pancreatic benign or low-grade malignant tumor: a report of 66 cases in a single institution
Annals of Pancreatic Cancer
2018;
1:
AB119
(23 April 2018)
Abstract
AB118. P093. Impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB118
(23 April 2018)
Abstract
AB117. P092. Safety of intraoperative pancreatoscopy for the investigation of main pancreatic duct involvement and assessment of skip lesions in operated main duct (MD) involving IPMNs: a feasibility study
Annals of Pancreatic Cancer
2018;
1:
AB117
(23 April 2018)
Abstract
AB116. P090. Preliminary results with laparoscopic pancreatoduodenectomy: a comparative series with open procedure in a single center
Annals of Pancreatic Cancer
2018;
1:
AB116
(23 April 2018)
Abstract
AB115. P089. Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis
Annals of Pancreatic Cancer
2018;
1:
AB115
(23 April 2018)
Abstract
AB114. P088. Comparison between robotic assisted and the ‘gold standard’ open approach for left sided cystic tumors of the pancreas: results from a single center
Annals of Pancreatic Cancer
2018;
1:
AB114
(23 April 2018)
Abstract
AB113. P087. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions
Annals of Pancreatic Cancer
2018;
1:
AB113
(23 April 2018)
Abstract
AB112. P086. MicroRNA miR- 141/200c inhibit proliferation, invasion and metastasis of human pancreatic cancer cells by targeting WIPF1-YAP/TAZ pathway
Annals of Pancreatic Cancer
2018;
1:
AB112
(23 April 2018)
Abstract
AB111. P085. The key factors related to the postoperative survival duration of patients with pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB111
(23 April 2018)
Abstract
AB110. P084. OGDHL inhibits human pancreatic ductal adenocarcinoma progression and is regulated by microRNA-214/TWIST1 negative feedback pathway
Annals of Pancreatic Cancer
2018;
1:
AB110
(23 April 2018)
Abstract
AB109. P083. Low expression of KLF9 in pancreatic cancer and its correlation with tumor differentiations
Annals of Pancreatic Cancer
2018;
1:
AB109
(23 April 2018)
Abstract
AB108. P082. Role of epigenetic modifying enzymes in the chemoresistance of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB108
(23 April 2018)
Abstract
AB107. P081. Metabolic oligosaccharide engineering of pancreatic cells: measurement of sialylation and identification of sialylated glycoproteins
Annals of Pancreatic Cancer
2018;
1:
AB107
(23 April 2018)
Abstract
AB106. P080. Interferon gamma-inducible protein 10 in pancreatic cancer progression
Annals of Pancreatic Cancer
2018;
1:
AB106
(23 April 2018)
Abstract
AB105. P079. Impact of extravasated platelet activation surrounding cancer associated fibroblasts by neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB105
(23 April 2018)
Abstract
AB104. P078. Exosomal microRNAs in pancreatic juice have possibility as biomarkers to detect pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB104
(23 April 2018)
Abstract
AB103. P077. Preoperative biomarker panel distinguishes PDAC from IPMN
Annals of Pancreatic Cancer
2018;
1:
AB103
(23 April 2018)
Abstract
AB102. P076. Preoperative panel of CA 19-9, coagulation FVIII, fibrin turnover marker D-dimer and thrombin time predicts postoperative survival in pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB102
(23 April 2018)
Abstract
AB101. P75. Surgical management of pancreatic neuroendocrine neoplasms (PNENs) in a single center
Annals of Pancreatic Cancer
2018;
1:
AB101
(23 April 2018)
Abstract
AB100. P074. Novel biomarkers for differential diagnosis of intraductal papillary mucinous neoplasms revealed by profiling microbial composition and translocation markers in liquid biopsies
Annals of Pancreatic Cancer
2018;
1:
AB100
(23 April 2018)
Abstract
AB099. P073. Clinicopathological analysis of cystic pancreatic carcinoma in 31 cases
Annals of Pancreatic Cancer
2018;
1:
AB099
(23 April 2018)
Abstract
AB098. P072. Investigation of BRCAness in pancreatic cancer using patient-derived organoid models
Annals of Pancreatic Cancer
2018;
1:
AB098
(23 April 2018)
Abstract
AB097. P071. Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB097
(23 April 2018)
Abstract
AB096. P070. Feasibility and efficacy of an analysis using FFPE blocks of resected pancreas with micro CT
Annals of Pancreatic Cancer
2018;
1:
AB096
(23 April 2018)
Abstract
AB095. P069. Identification of therapeutic genomic alterations by investigating cancer-related genes and microsatellite instability: road to precision medicine for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB095
(23 April 2018)
Abstract
AB094. P067. Therapeutic strategies and prognosis in patients with borderline resectable pancreatic adenocarcinoma: a multicenter retrospective study
Annals of Pancreatic Cancer
2018;
1:
AB094
(23 April 2018)
Abstract
AB093. P066. Pancreaspreserving management of grade-c pancreatic fistulas after pancreaticoduodenectomy: a single center’s experience
Annals of Pancreatic Cancer
2018;
1:
AB093
(23 April 2018)
Abstract
AB092. P064. The preliminary experience of total or proximal intestinal derotation procedure applied in pancreatoduodenectomy
Annals of Pancreatic Cancer
2018;
1:
AB092
(23 April 2018)
Abstract
AB091. P063. Case report: stage 4 pancreatic cancer to remission using paricalcitol and hydroxychloroquine in addition to traditional chemotherapy
Annals of Pancreatic Cancer
2018;
1:
AB091
(23 April 2018)
Abstract
AB090. P062. Strategy of postoperative follow-up for intraductal papillary mucinous neoplasms
Annals of Pancreatic Cancer
2018;
1:
AB090
(23 April 2018)
Abstract
AB089. P061. Pancreatectomies associated to vein resection: a large single institution experience
Annals of Pancreatic Cancer
2018;
1:
AB089
(23 April 2018)
Abstract
AB088. P060. Safety assessment of standardized pancreatectomy in patients with solid pseudopapillary tumor and pancreatic ductal adenocarcinoma: retrospective case-control study in a single center
Annals of Pancreatic Cancer
2018;
1:
AB088
(23 April 2018)
Abstract
AB087. P059. Strategy for radical dissection of two anatomical difficult triangles for pancreatic head cancer—laparoscopic pancreaticoduodenectomy with left uncinate first approach
Annals of Pancreatic Cancer
2018;
1:
AB087
(23 April 2018)
Abstract
AB086. P058. Current status of pancreatic cystic neoplasm: diagnosis and treatment a multi-institution retrospective study in China
Annals of Pancreatic Cancer
2018;
1:
AB086
(23 April 2018)
Abstract
AB085. P057. Early monocentric experience in EUS-FNA wettechnique for pancreatic lesions
Annals of Pancreatic Cancer
2018;
1:
AB085
(23 April 2018)
Abstract
AB084. P056. Intra-operative ultrasound to determine resectability during surgical exploration of primary nonresectable pancreatic cancer following induction chemotherapy
Annals of Pancreatic Cancer
2018;
1:
AB084
(23 April 2018)
Abstract
AB083. P055. Total pancreatectomy in radical pancreatectomy for pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB083
(23 April 2018)
Abstract
AB082. P054. Non-functional pancreatic neuroendocrine tumor (NF PNET) imaging and evaluation using 18F-FDG and 68Ga-DOTANOC-PET/CT: initial data of a prospective study
Annals of Pancreatic Cancer
2018;
1:
AB082
(23 April 2018)
Abstract
AB081. P053 Survival of unresectable pancreatic cancer patients after artery divestment combined pancreatectomy: a retrospective and propensity score-matched analysis
Annals of Pancreatic Cancer
2018;
1:
AB081
(23 April 2018)
Abstract
AB080. P052. Role of neutrophil extracellular traps (NETs) in pancreatic cancer liver metastasis
Annals of Pancreatic Cancer
2018;
1:
AB080
(23 April 2018)
Abstract
AB079. P051. Blockage of CTR1-dependent copper absorption increases autophagy to resist apoptosis of pancreatic ductal carcinoma cells
Annals of Pancreatic Cancer
2018;
1:
AB079
(23 April 2018)
Abstract
AB078. P050. Efficacy of integrated immune ratio associated with tumor growth and prognosis in pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB078
(23 April 2018)
Abstract
AB077. P049. Genetic relationship of pancreatic ductal adenocarcinoma and co-occurring IPMN
Annals of Pancreatic Cancer
2018;
1:
AB077
(23 April 2018)
Abstract
AB076. P048. Microsatellite instability and tumor volume inversely affect early progression free survival in adjuvant setting of patients with pancreatic ductal adenocarcinoma: lights and shadows of molecular pathology and immunotherapy
Annals of Pancreatic Cancer
2018;
1:
AB076
(23 April 2018)
Abstract
AB075. P047. Human pancreatic stellate cells secreted fibronectin promote chemoresistance to gemcitabine in PDAC
Annals of Pancreatic Cancer
2018;
1:
AB075
(23 April 2018)
Abstract
AB074. P046. Comprehensive analysis of links between diabetes and pancreatic cancer: a bioinformatical approach
Annals of Pancreatic Cancer
2018;
1:
AB074
(23 April 2018)
Abstract
AB073. P045. Mutant GNAS drives pancreatic tumorigenesis via PKA-SIK signaling and reprogramming lipid metabolism
Annals of Pancreatic Cancer
2018;
1:
AB073
(23 April 2018)
Abstract
AB072. P044. Analyses of aberrant methylation of tumor suppressive miRNAs in the patients with pancreaticobiliary diseases in bile juice
Annals of Pancreatic Cancer
2018;
1:
AB072
(23 April 2018)
Abstract
AB071. P043. TLR1 predicts favorable prognosis in young pancreatic cancer patients
Annals of Pancreatic Cancer
2018;
1:
AB071
(23 April 2018)
Abstract
AB070. P042. Serum protein profile in IPMN
Annals of Pancreatic Cancer
2018;
1:
AB070
(23 April 2018)
Abstract
AB069. P041. A nomogram based on postoperative neutrophil-to-lymphocyte rate and TNM stage to predict the prognostic value in pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy
Annals of Pancreatic Cancer
2018;
1:
AB069
(23 April 2018)
Abstract
AB068. P040. Heterotopic ossification in abdominal surgery incisions as an independent predictor of prognosis of malignant abdominal tumors: a casecontrol study from a single institution
Annals of Pancreatic Cancer
2018;
1:
AB068
(23 April 2018)
Abstract
AB067. P039. Rab37 mediates exosomal osteopontin secretion to promote pancreatic cancer metastasis and stemness
Annals of Pancreatic Cancer
2018;
1:
AB067
(23 April 2018)
Abstract
AB066. P038. HHLA2 is overexpressed in pancreatic ductal adenocarcinoma and precancerous lesions
Annals of Pancreatic Cancer
2018;
1:
AB066
(23 April 2018)
Abstract
AB065. P037. Prognostic role of the parenchymal frozen transection margin during pancreaticoduodenectomy (PD) for ductal pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB065
(23 April 2018)
Abstract
AB064. P036. Fat tissue and pancreatic parenchyma play different roles in pancreatic cancer invasion
Annals of Pancreatic Cancer
2018;
1:
AB064
(23 April 2018)
Abstract
AB063. P035. Radiofrequency ablation and irreversible electroporation in locally advanced pancreatic cancer: competitive or complementary treatment modalities?
Annals of Pancreatic Cancer
2018;
1:
AB063
(23 April 2018)
Abstract
AB062. P034. Prior cholecystectomy and the survival of resected pancreatic cancer: a single-center retrospective cohort in Chinese population
Annals of Pancreatic Cancer
2018;
1:
AB062
(23 April 2018)
Abstract
AB061. P033. A comparison of delayed gastric emptying and nutritional status after pylorus-preserving versus stomach-preserving pancreaticoduodenectomy
Annals of Pancreatic Cancer
2018;
1:
AB061
(23 April 2018)
Abstract
AB060. P032. 2,029 cases of Whipple’s procedure: 12-year experience from a single center
Annals of Pancreatic Cancer
2018;
1:
AB060
(23 April 2018)
Abstract
AB059. P031. Outcomes of pylorus-preserving versus conventional pancreaticoduodenectomy in the era of enhanced recovery: a single-institution experience
Annals of Pancreatic Cancer
2018;
1:
AB059
(23 April 2018)
Abstract
AB058. P030. The 8th versus the 7th edition of the AJCC Cancer Staging Manual in predicting the prognosis of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB058
(23 April 2018)
Abstract
AB057. P029. Rescue ERCP with pancreatic stent replacement against post- ERCP pancreatitis following prophylactic pancreatic stent placement
Annals of Pancreatic Cancer
2018;
1:
AB057
(23 April 2018)
Abstract
AB056. P027. Preoperative chemotherapy for resectable pancreatic cancer improves prognosis of node positive pancreatic head cancer
Annals of Pancreatic Cancer
2018;
1:
AB056
(23 April 2018)
Abstract
AB055. P026. Prediction of clinically relevant pancreatic fistula in the early phase after distal pancreatectomy
Annals of Pancreatic Cancer
2018;
1:
AB055
(23 April 2018)
Abstract
AB054. P025. Impact of pasireotide on post-operative pancreatic fistulas after pancreatic distal resections
Annals of Pancreatic Cancer
2018;
1:
AB054
(23 April 2018)
Abstract
AB053. P024. Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma: does it have a prognostic role?
Annals of Pancreatic Cancer
2018;
1:
AB053
(23 April 2018)
Abstract
AB052. P023. Diagnosis and management of postpancreatectomy hemorrhage: a systematic review and meta-analysis
Annals of Pancreatic Cancer
2018;
1:
AB052
(23 April 2018)
Abstract
AB051. P022. Vein invasion in pancreatic adenocarcinoma is a topography: vein resection in pancreaticoduodenectomy is worthy while
Annals of Pancreatic Cancer
2018;
1:
AB051
(23 April 2018)
Abstract
AB050. P021. The impact of surgical experience and work routine on operative morbidity and mortality in pancreatic surgery
Annals of Pancreatic Cancer
2018;
1:
AB050
(23 April 2018)
Abstract
AB049. P020. Robotic pancreatoduodenectomy: results of the first twenty procedures
Annals of Pancreatic Cancer
2018;
1:
AB049
(23 April 2018)
Abstract
AB048. P019. Middle segment pancreatectomy: the complications and safety
Annals of Pancreatic Cancer
2018;
1:
AB048
(23 April 2018)
Abstract
AB047. P018. A technical refinement of the pancreaticojejunostomy after pancreatoduodenectomy (PD): the pancreas encompassing jejunal anastomosis (PEJA)
Annals of Pancreatic Cancer
2018;
1:
AB047
(23 April 2018)
Abstract
AB046. P017. Identification of pathological ampullary adenocarcinomas subtypes and their prognosis using the immunohistochemical score of CDX2, CK7 and CK 20
Annals of Pancreatic Cancer
2018;
1:
AB046
(23 April 2018)
Abstract
AB045. P016. Profile of neoepitopes on human pancreas tumor tissue by proteomics
Annals of Pancreatic Cancer
2018;
1:
AB045
(23 April 2018)
Abstract
AB044. P015. Clinicopathological relevance of SMAD4 and RUNX3 in pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB044
(23 April 2018)
Abstract
AB043. P014. Genomic characterization of pancreatic cancer in Chinese population
Annals of Pancreatic Cancer
2018;
1:
AB043
(23 April 2018)
Abstract
AB042. P013. LncRNAPTCHD3P1 enhances chemosensitivity of gemcitabine in pancreatic cancer and inhibits cancer cell proliferation and metastasis via inhibiting Warburg effect
Annals of Pancreatic Cancer
2018;
1:
AB042
(23 April 2018)
Abstract
AB041. P012. The effect of pancreatic cancer patient derived serum on macrophage M1/M2 polarization
Annals of Pancreatic Cancer
2018;
1:
AB041
(23 April 2018)
Abstract
AB040. P011. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB040
(23 April 2018)
Abstract
AB039. P010. Use GeCKO lentiviral pooled libraries screen to identify genes which contribute to chemoresistance of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB039
(23 April 2018)
Abstract
AB038. P009. Tyrosine kinases and their prognostic value in digestive tract cancers
Annals of Pancreatic Cancer
2018;
1:
AB038
(23 April 2018)
Abstract
AB037. P008. Intratumoral regulatory T cells (Tregs) reduced by neutralization TGF-β in murine pancreatic ductal adenocarcinoma model without promising functional change
Annals of Pancreatic Cancer
2018;
1:
AB037
(23 April 2018)
Abstract
AB036. P007. BM-derived cells differentiated into multilineage hematopoietic cells regulate invasion and proliferation of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB036
(23 April 2018)
Abstract
AB035. P006. Activity of heat shock protein-90 (HSP90) inhibitors against pancreatic cancers grown in 3 dimensions
Annals of Pancreatic Cancer
2018;
1:
AB035
(23 April 2018)
Abstract
AB034. P005. What is the role of central pancreatectomy in pancreatic surgery? —a systematic review and metaanalysis
Annals of Pancreatic Cancer
2018;
1:
AB034
(23 April 2018)
Abstract
AB033. P003. Identification of germline mutations in cancer predisposition genes in patients with a personal and/or family history of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB033
(23 April 2018)
Abstract
AB032. P002. Radiomics based classification of pancreatic cystic neoplasms
Annals of Pancreatic Cancer
2018;
1:
AB032
(23 April 2018)
Abstract
AB031. P001. The value of infectious biomarkers for prediction of complication after pancreatic surgery
Annals of Pancreatic Cancer
2018;
1:
AB031
(23 April 2018)
Abstract
AB030. S030. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB030
(23 April 2018)
Abstract
AB029. S029. Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB029
(23 April 2018)
Abstract
AB028. S028. Risk of the serous cystic neoplasms in pancreas results from no surgical intervention: a multi-center retrospective study
Annals of Pancreatic Cancer
2018;
1:
AB028
(23 April 2018)
Abstract
AB027. S027. Factors associated with invasive intraductal papillary mucinous carcinoma
Annals of Pancreatic Cancer
2018;
1:
AB027
(23 April 2018)
Abstract
AB026. S026. What is the optimal surgical strategy for grade-C pancreatic fistula after pancreaticoduodenectomy? A large retrospective multicenter study
Annals of Pancreatic Cancer
2018;
1:
AB026
(23 April 2018)
Abstract
AB025. S025. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB025
(23 April 2018)
Abstract
AB024. S024. Drug responses of patient-derived cell lines in vitro that match drug responses of patient PDAc tumors in situ
Annals of Pancreatic Cancer
2018;
1:
AB024
(23 April 2018)
Abstract
AB023. S023. Identification and targeting of a poor-prognosis subgroup of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB023
(23 April 2018)
Abstract
AB022. S022. A continuous clonal labeling method to reveal growth dynamics in developing, adult and injured pancreas
Annals of Pancreatic Cancer
2018;
1:
AB022
(23 April 2018)
Abstract
AB021. S021. Expression patterns and clinical implications of immunotherapy targets PD-1, PD-L1 and CD163 in undifferentiated carcinoma of the pancreas with osteoclastlike giant cells
Annals of Pancreatic Cancer
2018;
1:
AB021
(23 April 2018)
Abstract
AB020. S020. Importance of adjuvant hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil with systemic gemcitabine for resectable pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB020
(23 April 2018)
Abstract
AB019. S019. Pancreatectomy plus arterial resection is superior to palliation in patients with locally advanced PDAC
Annals of Pancreatic Cancer
2018;
1:
AB019
(23 April 2018)
Abstract
AB018. S018. The prognostic impact of primary tumor resection in pancreatic neuroendocrine tumors with synchronous multifocal liver metastases
Annals of Pancreatic Cancer
2018;
1:
AB018
(23 April 2018)
Abstract
AB017. S017. Is main pancreatic duct dilation really an independent risk factor for malignancy in main-duct and combined-IPMNs?
Annals of Pancreatic Cancer
2018;
1:
AB017
(23 April 2018)
Abstract
AB016. S016. Lymphadenectomy in resected node-negative pancreatic cancer: are some patients being understaged?
Annals of Pancreatic Cancer
2018;
1:
AB016
(23 April 2018)
Original Article
Robotic distal pancreatectomy: experience in a high-volume center
Annals of Pancreatic Cancer
2018;
1:
15
(10 April 2018)
Abstract
AB015. S015. Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: data from a prospective trial
Annals of Pancreatic Cancer
2018;
1:
AB015
(23 April 2018)
Abstract
AB014. S014. Fractional uptake of circulating tumor cells across liver-lung compartments during resections of periampullary cancer aimed at cure
Annals of Pancreatic Cancer
2018;
1:
AB014
(23 April 2018)
Abstract
AB013. S013. Towards early detection of pancreatic cancer: applying NGS in the clinical setup
Annals of Pancreatic Cancer
2018;
1:
AB013
(23 April 2018)
Abstract
AB012. S012. Immunophenotypes of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB012
(23 April 2018)
Abstract
AB011. S011. Mesenchymal pancreatic cancer cells inhibit pancreatic stellate cell activation
Annals of Pancreatic Cancer
2018;
1:
AB011
(23 April 2018)
Abstract
AB010. S010. Pancreatic cystic lesions’ follow-up with abdominal ultrasound scan: could it play an alternative role to the routine use of MRI?
Annals of Pancreatic Cancer
2018;
1:
AB010
(23 April 2018)
Abstract
AB009. S009. Effect of endoscopic iodine 125 seeds brachytherapy on advanced pancreatic cancer: experience of single center
Annals of Pancreatic Cancer
2018;
1:
AB009
(23 April 2018)
Abstract
AB008. S008. Diagnostic yield of intraoperative pancreatoscopy for the investigation of pancreatic IPMN
Annals of Pancreatic Cancer
2018;
1:
AB008
(23 April 2018)
Abstract
AB007. S007. Survival in locally advanced pancreatic cancer: impact of surgical resection after neoadjuvant therapy
Annals of Pancreatic Cancer
2018;
1:
AB007
(23 April 2018)
Abstract
AB006. S006. Variation in longterm oncologic outcomes by types of cancer center accreditation: an analysis of a SEER-Medicare population with pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB006
(23 April 2018)
Abstract
AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors
Annals of Pancreatic Cancer
2018;
1:
AB005
(23 April 2018)
Abstract
AB004. S004. Differences in cancer metabolism between subtypes of pancreatic ductal adenocarcinoma (PDAC) are associated with survival and offer therapeutic opportunities
Annals of Pancreatic Cancer
2018;
1:
AB004
(23 April 2018)
Abstract
AB003. S003. BRCA1/BRCA2 germline mutation carriers and sporadic pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB003
(23 April 2018)
Abstract
AB002. S002. Wild-type KRAS allele exerts its tumorsuppressive function through decreased Yap1 activation in pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB002
(23 April 2018)
Abstract
AB001. S001. Defining DDR deficiency and replication stress in pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB001
(23 April 2018)